HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Min Zheng Selected Research
Min Zheng Research Topics
Disease
150
Neoplasms (Cancer)
06/2022 - 07/2004
48
Infections
01/2022 - 06/2004
37
Psoriasis (Pustulosis Palmaris et Plantaris)
10/2022 - 12/2003
36
Inflammation (Inflammations)
10/2022 - 11/2003
31
Hepatocellular Carcinoma (Hepatoma)
01/2022 - 08/2002
30
Neoplasm Metastasis (Metastasis)
06/2022 - 08/2002
24
Carcinogenesis
01/2021 - 04/2008
19
Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 04/2010
18
Fibrosis (Cirrhosis)
12/2022 - 04/2002
14
Carcinoma (Carcinomatosis)
10/2019 - 08/2002
13
Breast Neoplasms (Breast Cancer)
01/2022 - 04/2008
10
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 12/2016
9
Lymphatic Metastasis
06/2022 - 02/2010
9
Virus Diseases (Viral Diseases)
01/2022 - 03/2011
9
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 01/2004
9
Liver Neoplasms (Liver Cancer)
10/2020 - 08/2002
8
Necrosis
12/2022 - 04/2008
8
Liver Cirrhosis (Hepatic Cirrhosis)
12/2022 - 11/2003
8
Lung Neoplasms (Lung Cancer)
01/2022 - 02/2008
8
Hypoxia (Hypoxemia)
12/2021 - 04/2008
7
Liver Diseases (Liver Disease)
08/2021 - 01/2017
7
Squamous Cell Carcinoma of Head and Neck
04/2020 - 07/2009
7
Diabetic Nephropathies (Diabetic Nephropathy)
01/2018 - 01/2011
6
COVID-19
01/2022 - 11/2020
6
Adenoid Cystic Carcinoma (Cylindroma)
01/2021 - 11/2010
6
Glioma (Gliomas)
01/2020 - 01/2014
5
Colitis
05/2022 - 01/2013
5
Fever (Fevers)
06/2021 - 08/2009
5
Myocardial Infarction
05/2021 - 01/2004
5
Chronic Renal Insufficiency
01/2021 - 03/2012
5
Type 2 Diabetes Mellitus (MODY)
01/2021 - 06/2011
5
Ovarian Epithelial Carcinoma
07/2020 - 10/2010
4
Stroke (Strokes)
01/2022 - 01/2009
4
Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 07/2004
4
Ischemia
01/2022 - 08/2010
4
Heart Failure
12/2021 - 01/2012
4
Reperfusion Injury
05/2021 - 05/2003
4
Chronic Hepatitis B
01/2021 - 04/2004
4
Human Influenza (Influenza)
01/2020 - 09/2011
Drug/Important Bio-Agent (IBA)
65
Proteins (Proteins, Gene)
FDA Link
06/2022 - 08/2002
31
Biomarkers (Surrogate Marker)
IBA
10/2022 - 05/2010
30
Messenger RNA (mRNA)
IBA
01/2020 - 04/2002
25
Pharmaceutical Preparations
IBA
01/2022 - 06/2008
23
Cytokines
IBA
01/2022 - 03/2011
17
MicroRNAs (MicroRNA)
IBA
01/2021 - 05/2008
13
DNA (Deoxyribonucleic Acid)
IBA
01/2021 - 01/2006
13
Transcription Factors (Transcription Factor)
IBA
04/2020 - 11/2010
13
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
05/2019 - 07/2006
12
RNA (Ribonucleic Acid)
IBA
01/2021 - 04/2004
11
Enzymes
IBA
10/2022 - 11/2003
11
Inflammasomes
IBA
01/2022 - 01/2018
11
Glucose (Dextrose)
FDA Link
Generic
12/2021 - 12/2007
9
Biological Products
IBA
01/2019 - 02/2013
8
Antiviral Agents (Antivirals)
IBA
10/2022 - 03/2010
8
Therapeutic Uses
IBA
01/2022 - 04/2006
8
Long Noncoding RNA
IBA
08/2020 - 06/2014
8
Small Interfering RNA (siRNA)
IBA
01/2020 - 09/2008
8
Focal Adhesion Protein-Tyrosine Kinases
IBA
07/2013 - 04/2008
7
Interleukin-6 (Interleukin 6)
IBA
01/2022 - 02/2014
7
Carbon
IBA
12/2021 - 11/2015
7
Peptidylprolyl Isomerase (Prolyl Isomerase)
IBA
01/2020 - 04/2015
7
Tretinoin (Retinoic Acid)
FDA Link
Generic
01/2020 - 06/2015
7
Antigens
IBA
01/2019 - 01/2009
7
Hyaluronic Acid (Hyaluronan)
IBA
09/2013 - 12/2002
7
Phosphotransferases (Kinase)
IBA
07/2013 - 04/2008
6
Lipids
IBA
01/2022 - 07/2014
6
Platinum
IBA
01/2022 - 02/2014
6
Lipopolysaccharides
IBA
12/2021 - 01/2014
6
Indicators and Reagents (Reagents)
IBA
01/2020 - 10/2010
5
Ligands
IBA
01/2022 - 03/2010
5
Vaccines
IBA
12/2021 - 08/2009
5
Anti-Bacterial Agents (Antibiotics)
IBA
05/2021 - 11/2011
5
Antioxidants
IBA
05/2021 - 01/2017
5
Bile Acids and Salts (Bile Acids)
IBA
04/2021 - 01/2017
5
Cadherins (E-Cadherin)
IBA
04/2021 - 04/2014
5
Chemokines
IBA
01/2021 - 05/2011
5
Solutions
IBA
10/2020 - 05/2010
5
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
08/2020 - 01/2007
5
Catenins
IBA
01/2020 - 04/2014
5
Reactive Oxygen Species (Oxygen Radicals)
IBA
10/2019 - 04/2008
5
Collagen
IBA
01/2019 - 01/2013
5
squamous cell carcinoma-related antigen
IBA
12/2018 - 01/2007
5
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
01/2018 - 12/2003
4
Monoclonal Antibodies
IBA
01/2022 - 08/2008
4
Sorafenib (BAY 43-9006)
FDA Link
01/2022 - 05/2017
4
Histones (Histone)
IBA
05/2021 - 01/2017
4
Doxorubicin (Adriamycin)
FDA Link
Generic
05/2021 - 01/2012
4
Interferon Type I
IBA
01/2021 - 03/2011
4
Etanercept (Enbrel)
FDA Link
08/2020 - 01/2016
4
ceric oxide (cerium dioxide)
IBA
12/2019 - 11/2018
4
Peptides (Polypeptides)
IBA
12/2018 - 12/2002
Therapy/Procedure
69
Therapeutics
06/2022 - 04/2003
19
Drug Therapy (Chemotherapy)
01/2022 - 02/2008
7
Radiotherapy
10/2019 - 09/2008
6
Photochemotherapy (Photodynamic Therapy)
01/2022 - 04/2013
6
Immunotherapy
01/2022 - 01/2019
6
Hysterectomy
03/2021 - 04/2010
6
Transplantation
12/2017 - 01/2004
5
Lasers (Laser)
01/2022 - 01/2003
4
Injections
10/2020 - 04/2010